Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists

• Main Authors: Mateusz Małkowski (Author), Agnieszka Almgren-Rachtan (Author), Magdalena Olszanecka-Glinianowicz (Author), Jerzy Chudek (Author), Piotr Chłosta (Author)
• פורמט: ספר
• יצא לאור: MDPI AG, 2024-01-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Solifenacin, a selective muscarinic receptor antagonist, is one of the best-tolerated and most effective medicines that relieve storage symptoms in patients with an overactive bladder (OAB). However, the persistence of solifenacin in daily clinical practice remains far below that reported in clinica...